TIAA Trust National Association Grows Stake in Agilent Technologies, Inc. (NYSE:A)

TIAA Trust National Association raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 3.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,505 shares of the medical research company’s stock after acquiring an additional 121 shares during the quarter. TIAA Trust National Association’s holdings in Agilent Technologies were worth $510,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies in the 4th quarter valued at about $26,000. MV Capital Management Inc. raised its position in Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after purchasing an additional 105 shares during the period. VisionPoint Advisory Group LLC purchased a new stake in Agilent Technologies in the fourth quarter valued at approximately $29,000. Rise Advisors LLC increased its position in shares of Agilent Technologies by 527.8% during the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after acquiring an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. purchased a new stake in shares of Agilent Technologies during the first quarter worth $34,000.

Wall Street Analyst Weigh In

Several brokerages have issued reports on A. Wolfe Research lowered Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. Robert W. Baird cut their price objective on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating for the company in a research report on Thursday, May 30th. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Stifel Nicolaus cut their price target on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a report on Thursday, May 30th. Finally, Barclays lowered their price objective on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $138.06.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares in the company, valued at $3,274,050. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the transaction, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Trading Down 0.1 %

A stock traded down $0.19 on Friday, reaching $131.78. The company’s stock had a trading volume of 1,731,443 shares, compared to its average volume of 2,258,323. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15. The firm has a market cap of $38.45 billion, a PE ratio of 31.15, a PEG ratio of 4.47 and a beta of 1.05. The business has a fifty day simple moving average of $136.39 and a two-hundred day simple moving average of $137.49. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.19 by $0.03. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The company had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same period last year, the company earned $1.27 EPS. Agilent Technologies’s revenue for the quarter was down 8.4% on a year-over-year basis. As a group, research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be given a $0.236 dividend. This represents a $0.94 annualized dividend and a yield of 0.72%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.